Point72 Europe’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-267,649
Closed -$1.65M 123
2024
Q2
$1.65M Buy
+267,649
New +$1.65M 0.14% 109